These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31296552)

  • 41. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
    Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration.
    Newmeyer MN; Swortwood MJ; Taylor ME; Abulseoud OA; Woodward TH; Huestis MA
    J Appl Toxicol; 2017 Aug; 37(8):922-932. PubMed ID: 28138971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
    Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
    J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
    Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Passive cannabis smoke exposure and oral fluid testing.
    Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.
    Jones AW; Holmgren A; Kugelberg FC
    Addiction; 2008 Mar; 103(3):452-61. PubMed ID: 18190663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry.
    Huang W; Moody DE; Andrenyak DM; Smith EK; Foltz RL; Huestis MA; Newton JF
    J Anal Toxicol; 2001 Oct; 25(7):531-7. PubMed ID: 11599596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop.
    Röhrich J; Schimmel I; Zörntlein S; Becker J; Drobnik S; Kaufmann T; Kuntz V; Urban R
    J Anal Toxicol; 2010 May; 34(4):196-203. PubMed ID: 20465865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Time profile of serum THC levels in occasional and chronic marihuana smokers after acute drog use - implication for drivind motor vehicles].
    Balíková M; Hložek T; Páleníček T; Tylš F; Viktorinová M; Melicher T; Androvičová R; Tomíček P; Roman M; Horáček J
    Soud Lek; 2014; 59(1):2-6. PubMed ID: 24625019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects.
    Cone EJ; Bigelow GE; Herrmann ES; Mitchell JM; LoDico C; Flegel R; Vandrey R
    J Anal Toxicol; 2015 Sep; 39(7):497-509. PubMed ID: 26139312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabinoid concentrations in spot serum samples 24-48 hours after discontinuation of cannabis smoking.
    Skopp G; Pötsch L
    J Anal Toxicol; 2008 Mar; 32(2):160-4. PubMed ID: 18334100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid glucuronide (THC-COOH-glu) in hair by ultra-performance liquid chromatography tandem mass spectrometry as a potential hair biomarker of cannabis use.
    Pichini S; Marchei E; Martello S; Gottardi M; Pellegrini M; Svaizer F; Lotti A; Chiarotti M; Pacifici R
    Forensic Sci Int; 2015 Apr; 249():47-51. PubMed ID: 25659366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility?
    Hädener M; Martin Fabritius M; König S; Giroud C; Weinmann W
    Drug Test Anal; 2017 Jul; 9(7):1043-1051. PubMed ID: 27732768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cannabis use: a perspective in relation to the proposed UK drug-driving legislation.
    Wolff K; Johnston A
    Drug Test Anal; 2014; 6(1-2):143-54. PubMed ID: 24327278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ
    Newmeyer MN; Swortwood MJ; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2017 Mar; 63(3):647-662. PubMed ID: 28188235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exercise increases plasma THC concentrations in regular cannabis users.
    Wong A; Montebello ME; Norberg MM; Rooney K; Lintzeris N; Bruno R; Booth J; Arnold JC; McGregor IS
    Drug Alcohol Depend; 2013 Dec; 133(2):763-7. PubMed ID: 24018317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. THCCOOH concentrations in whole blood: are they useful in discriminating occasional from heavy smokers?
    Fabritius M; Favrat B; Chtioui H; Battistella G; Annoni JM; Appenzeller M; Dao K; Fornari E; Lauer E; Mall JF; Maeder P; Mangin P; Staub C; Giroud C
    Drug Test Anal; 2014; 6(1-2):155-63. PubMed ID: 24173827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can a threshold for 11-nor-9-carboxy-Δ
    Zinka B; Epple S; Schick S; Skopp G; Graw M; Musshoff F
    Drug Test Anal; 2019 Feb; 11(2):325-330. PubMed ID: 30193411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.